logo-loader

Premaitha Health PLC bags tenth customer

Published: 08:21 29 Mar 2016 BST

test-tubes
The company has pioneered a non-invasive test for Down's Syndrome.

Premaitha Health PLC (LON:NIPT) has landed a tenth customer for its IONA diagnostic, Europe’s first CE-marked non-invasive DNA-based pre-natal test for Down’s Syndrome.

The customer is an unnamed laboratory in France, the second signed up by local distributor AdGeniX.

Chief executive Stephen Little said: "With one lab already live in France and the second expected to be operational in the second quarter this year, the IONA test is making it easier for women in France to access a safe and accurate test for prenatal screening.

"With an estimated 800,000 births a year, France is an important market for Premaitha. Following today's agreement, we now have ten customer laboratories offering the IONA test in the UK and internationally, which is a significant milestone in our first year since the IONA test was launched, and also creates very strong foundations for future growth."

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

1 hour, 45 minutes ago